News
Alphabet and Microsoft: Billion Dollar AI Bettors
The 2025 Q4 earnings season continues to move at a rapid pace, with a fair chunk of S&P 500 companies already delivering their results. Among the bunch have been most of the Mag 7 members, including
Pre-Markets Open in Green to Close the Week
Pre-market futures have come back up for air this morning, after spending much of this trading week in the red — most notably yesterday. What began as a rotation out of high-priced, highly
BEN's January AUM Rises 1.3% Sequentially: What's Driving Growth?
Franklin Resources, Inc. BEN reported preliminary assets under management (AUM) of $1.71 trillion as of Jan. 31, 2026, reflecting a 1.3% increase from the prior month. The rise was primarily driven
Paylocity Q2 Earnings Beat Estimates, Revenues Increase Y/Y
Paylocity PCTY reported second-quarter fiscal 2026 non-GAAP net income of $1.85 per share, beating the Zacks Consensus Estimate by 17.83%. Paylocity's revenues rose 10.4% year over year to $416.1
Lightspeed Commerce Q3 Earnings Beat Estimates, Revenues Rise Y/Y
Lightspeed Commerce LSPD reported fiscal third-quarter earnings of 15 cents per share, beating the Zacks Consensus Estimate by 21.66%. The bottom line increased 25% year over year.
In the third
Amazon Q4 Earnings Miss Estimates, Shares Slide on $200B Capex Plan
Amazon.com AMZN shares dipped in after-hours trading on Thursday after the company delivered fourth-quarter 2025 earnings of $1.95 per share, which increased 5% from the year-ago quarter but fell
Pfizer Bets Big on Obesity and Oncology With 2026 Pipeline Push
In 2025, Pfizer PFE upped its efforts to rebuild its pipeline through acquisitions. Pfizer invested around $9 billion in M&A deals, including the acquisition of Metsera and the licensing deal with
5 Reasons GM Expects North America Margins to Improve in 2026
North America is the most important market for General Motors GM. The U.S. auto giant expects its North America EBIT margins to return to the 8-10% range in 2026, implying an improvement from 6.8%
Arrow Electronics Q4 Earnings Beat Estimates, Revenues Rise Y/Y
Arrow Electronics ARW reported fourth-quarter earnings of $4.39 per share, beating the Zacks Consensus Estimate by 23.66%. The bottom line increased 48% year over year.In the fourth quarter, ARW
Philip Morris Q4 Earnings Beat Estimates, Revenues Grow 6.8% Y/Y
Philip Morris International Inc. PM reported fourth-quarter 2025 results, with both top and bottom lines increasing year over year. Net sales missed the Zacks Consensus Estimate, while earnings beat
Merck's Subdued 2026 Outlook: What it Means After Q4 Results?
Merck MRK announced better-than-expected fourth-quarter results on Feb. 3. Along with its earnings release, the company issued a fresh earnings and sales outlook for 2026, which fell short of
How Should Investors Approach UBER Stock Post Q4 Earnings Miss?
On Feb. 4, San Francisco, CA-based Uber Technologies UBER reported lower-than-expected earnings per share for the fourth quarter of 2025, causing its shares to lose value. Moreover, the earnings
Regency Centers Q4 FFO Meet Estimates, Same-Property NOI Rises
Regency Centers Corporation (REG) reported fourth-quarter 2025 NAREIT funds from operations (FFO) per share of $1.17, in line with the Zacks Consensus Estimate. The figure increased 7.3% from the
Fortinet Q4 Earnings & Revenues Beat Estimates, Increase Y/Y
Fortinet FTNT reported impressive fourth-quarter 2025 results, wherein both earnings and revenues surpassed the Zacks Consensus Estimate and improved year over year. Fortinet reported fourth-quarter
MCK Q3 Earnings & Sales Top Estimates, 2026 View Up
McKesson Corporation MCK reported third-quarter fiscal 2026 adjusted earnings per share (EPS) of $9.34, which beat the Zacks Consensus Estimate of $9.31 by 0.3%. The bottom line improved 16.3% on a
Bayer's Asundexian Shows 26% Stroke Reduction in Late-Stage Study
Bayer BAYRY presented positive results from the late-stage OCEANIC-STROKE study evaluating the use of its investigational, once-daily, oral, factor XIa inhibitor asundexian (50mg) compared to
ExxonMobil's Permian Push: Here's What Investors Should Know
Exxon Mobil Corporation XOM, a U.S. oil and gas giant, generates a significant portion of its revenues from exploration and production activities. The company’s upstream production growth is
Willdan Stock at 23.75X Forward P/E: Risk or Opportunity?
Willdan Group, Inc. WLDN has become one of the stronger performers in the Business Services space, but its valuation is now drawing closer scrutiny. With WLDN trading at about 23.75X forward
WEC Energy Beats Q4 Earnings Estimates, to Add More Renewable Assets
WEC Energy Group WEC reported fourth-quarter 2025 earnings of $1.42 per share, which beat the Zacks Consensus Estimate of $1.38 per share by 2.9%. The bottom line was missed by a penny, which has
Does Rigetti's $8.4M C-DAC Order Strengthen Its Path to Scale?
Rigetti Computing’s RGTI $8.4 million purchase orderto deliver a 108-qubit quantum computer from C-DAC marks a meaningful validation of its system-led scaling strategy, shifting the narrative beyond
Barrick Mining's Q4 Earnings and Sales Beat on Higher Gold Prices
Barrick Mining Corporation B recorded profits (on a reported basis) of $2,406 million or $1.43 per share for fourth-quarter 2025, up from $996 million or 57 cents per share in the year-ago quarter.
RAVE vs. ARKR: Which Restaurant Turnaround Stock Is More Compelling?
Restaurant operators continue to face a mixed operating backdrop marked by cautious consumer spending, cost pressures and the need to protect margins without sacrificing traffic. In this
Cboe Global's Q4 Earnings Beat Estimates on Higher Revenues
Cboe Global Markets, Inc. CBOE reported fourth-quarter 2025 adjusted earnings of $3.06 per share, which beat the Zacks Consensus Estimate by 4.4%. The bottom line increased 46% year over year. The
Pre-Markets Rebounding Ahead of Super Bowl Sunday
Friday, February 6th, 2026Pre-market futures have come back up for air this morning, after spending much of this trading week in the red — most notably yesterday. What began as a rotation out of
Hims & Hers Strengthens Platform-Led Digital Healthcare Model
The renowned health and wellness platform, Hims & Hers Health, Inc. HIMS, operates as a digital healthcare platform built on proprietary technology that integrates care delivery, data and


